Brilliant Violet 785™ anti-human CD4 300553 from BioLegend

Product Specs
ItemBrilliant Violet 785™ anti-human CD4
CompanyBioLegend
Price $198.00Supplier Page View Company Product Page
Catalog Number300553
Quantity25 tests
ApplicationsFC - Quality tested
Conjugate/TagBrilliant Violet 785™
FormatPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
ReactivityHuman
IsotypeMouse IgG1, kappa
CloneRPA-T4
HostMouse
Antibody TypePrimary
NCBI Full Gene NameCD4 molecule
NCBI Gene AliasesCD4mut, IMD79, Leu-3, OKT4D, T4
ClonalityMonoclonal
TargetCD4
ConcentrationLot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)

Add to Compare List

BioLegend

8999 BioLegend Way

San Diego, California 92121

United States

Phone: 1-877-246-5343 Toll-Free, USA & Canada
1-858-768-5800 International
Fax: 1-877-455-9587

Company Profile

Website: biolegend.com

(1) Dynamic transition of Tregs to cytotoxic phenotype amid systemic inflammation in Graves’ ophthalmopathyJCI InsightNovember 22, 2024Zhong Liu, Shu-Rui Ke, Zhuo-Xing Shi, Ming Zhou, Li Sun, Qi-Hang Sun, Bing Xiao, Dong-Liang Wang, Yan-Jin Huang, Jin-Shan Lin, et al.experiments include: FOXP3 (BioLegend, 126419; BioLegend, 320014); CD4 (BioLegend, 100443; BioLegend, 300553); CD25 (BioLegend, 102051); IL-10 (BioLegend, 505007); TGF-β1 (BioLegend, 141403); TGF-β (BioLegend,

(2) Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8(+) T cell responses post SARS-CoV-2 infectionImmunityApril 11, 2023Gao F, Mallajosyula V, Arunachalam PS, van der Ploeg K, Manohar M, Röltgen K, Yang F, Wirz O, Hoh R, Haraguchi E, et al.300406; RRID:AB_314060 anti-CD8,BD Biosciences,Cat# 563795; RRID:AB_2722501 anti-CD4,BioLegend,Cat# 300553; RRID:AB_2564381 anti-CCR7,BioLegend,Cat# 353236; RRID:AB_2563641 anti-CD45RA,BioLegend,Cat# 304138;

(3) CD73 activity of mesenchymal stromal cell-derived extracellular vesicle preparations is detergent-resistant and does not correlate with immunomodulatory capabilitiesCytotherapyFebruary 1, 2023Bauer FN, Tertel T, Stambouli O, Wang C, Dittrich R, Staubach S, Börger V, Hermann DM, Brandau S, Giebel B.

(4) Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variantsCell reportsJanuary 31, 2023Meyer S, Blaas I, Bollineni RC, Delic-Sarac M, Tran TT, Knetter C, Dai KZ, Madssen TS, Vaage JT, Gustavsen A, et al.

(5) MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung CancerCancer researchNovember 2, 2022Yoshida R, Saigi M, Tani T, Springer BF, Shibata H, Kitajima S, Mahadevan NR, Campisi M, Kim W, Kobayashi Y, et al.

(6) Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcomaNature communicationsSeptember 8, 2022Gyurdieva A, Zajic S, Chang YF, Houseman EA, Zhong S, Kim J, Nathenson M, Faitg T, Woessner M, Turner DC, et al.

(7) Facile discovery of surrogate cytokine agonistsCellApril 14, 2022Yen M, Ren J, Liu Q, Glassman CR, Sheahan TP, Picton LK, Moreira FR, Rustagi A, Jude KM, Zhao X, et al.

(8) A T-cell-based immunogenicity protocol for evaluating human antigen-specific responsesSTAR protocolsSeptember 17, 2021Cimen Bozkus C, Blazquez AB, Enokida T, Bhardwaj N.

(9) Single-cell transcriptomic analysis reveals disparate effector differentiation pathways in human T_reg compartmentNature communicationsJune 23, 2021Luo Y, Xu C, Wang B, Niu Q, Su X, Bai Y, Zhu S, Zhao C, Sun Y, Wang J, et al.following antibodies: PE-Cyanine7-anti-human CD4 (357410, Biolegend, 1/200), BV785-anti-human CD4 (300553, Biolegend, 1/200), APC-Cyanine7-anti-human CD3 (317341, Biolegend, 1/200), APC-anti-human CD25 (302610,

(10) Modeling cell-specific dynamics and regulation of the common gamma chain cytokinesCell reportsApril 27, 2021Farhat AM, Weiner AC, Posner C, Kim ZS, Orcutt-Jahns B, Carlson SM, Meyer AS.

(11) Chromatin Landscape Underpinning Human Dendritic Cell HeterogeneityCell reportsSeptember 22, 2020Leylek R, Alcántara-Hernández M, Granja JM, Chavez M, Perez K, Diaz OR, Li R, Satpathy AT, Chang HY, Idoyaga J.

(12) Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cellsJCI insightMarch 21, 2019Dawson NA, Lamarche C, Hoeppli RE, Bergqvist P, Fung VC, McIver E, Huang Q, Gillies J, Speck M, Orban PC, et al.

(13) Deep analysis of immune response and metabolic signature in children with food protein induced enterocolitis to cow's milkClinical and translational allergyJanuary 1, 2018Adel-Patient K, Lezmi G, Castelli FA, Blanc S, Bernard H, Soulaines P, Dumond P, Ah-Leung S, Lageix F, de Boissieu D, et al.

(14) Predominance of weakly cytotoxic, T-bet^LowEomes^Neg CD8⁺ T-cells in human gastrointestinal mucosa: implications for HIV infectionMucosal immunologyJuly 1, 2017Kiniry BE, Ganesh A, Critchfield JW, Hunt PW, Hecht FM, Somsouk M, Deeks SG, Shacklett BL.

(15) Induction of Th1/Th17 immune response by Mycobacterium tuberculosis: role of dectin-1, Mannose Receptor, and DC-SIGNJournal of leukocyte biologyDecember 1, 2009Zenaro E, Donini M, Dusi S.

(16) Convulsant activity of thiomalate; a possible metabolite of aurothiomalateThe Journal of pharmacy and pharmacologyApril 1, 1977P V Taberner

(17) TGF-β-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structuresImmunityJanuary 1, 0001"Chaurio RA, Anadon CM, Lee Costich T, Payne KK, Biswas S, Harro CM, Moran C, Ortiz AC, Cortina C, Rigolizzo KE, et al."

Write a Review

(1)

8/15/2016Staining PBMC With Anti-CD4 BV785 Adam GuessThis antibody was used to phenotype CD4+ T cells in human blood. It was chosen because it is a commonly used clone for CD4, BV785 works well in the staining panel, and Biolegend had the best price.

Brilliant Violet 785™ anti-human CD4 from BioLegend

Description

BioLegend

Citations (17)

Reviews

Brilliant Violet 785™ anti-human CD4 from BioLegend

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map